Immune response to intradermally administrated Ixiaro in healthy adults: a randomized study

Trial Profile

Immune response to intradermally administrated Ixiaro in healthy adults: a randomized study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2016

At a glance

  • Drugs IC 51 (Primary) ; IC 51 (Primary)
  • Indications Japanese encephalitis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Apr 2016 Planned number of patients changed from 180 to 240.
    • 16 Apr 2016 Phase of the trial is changed from phase II to phase IV as per European Clinical Trials Database record.
    • 08 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top